Humacyte, Inc.
HUMA
Jodie situation report
Humacyte, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 2 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 4 directly disclosed connections are confirming.
- HUMA's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if HUMA's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind HUMA
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
FMSFresenius Medical Care AGpartnerMay 13, 2026 ▾
“On April 21, 2026, we entered into the Third Amendment to our distribution agreement with Fresenius Medical Care.”
TMOThermo Fisher Scientific IncsupplierMar 27, 2026 ▾
“We source bioprocess solutions, including culture media and decellularization buffers, from a division of Thermo Fisher Scientific, which has a second production site to provide redundant media/buffer production capacity.”
FMSFresenius Medical Care AGdistributorMar 27, 2026 ▾
“Distribution Agreement with Fresenius Medical Care We entered into a distribution agreement with Fresenius Medical Care in June 2018 which, as amended as of February 16, 2021, granted Fresenius Medical Care and its affiliates exclusive rights to develop outsi…”
Filing peers
No filing peers are available for this name yet.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 1 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
HUMA is currently a Leader in the organic co-movement group Human Tissue Engineering. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for HUMA; it is not active in the latest market snapshot.